Clinical Trial Results TV

Main Menu

Series

Duke Clinical Medicine
SCAI TV

Categories


	Diabetes: 12 submissions

| Page 1 |

FDA Universal Definitions Used in Clinical Trials to Adjudicate Events for Diabetes Trials
Dr. Kenneth Mahaffey, Dr. C. Michael Gibson

Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiov
Dr. Henry Ginsberg

Dr. Bernard Chaitman and Dr. C. Michael Gibson discuss the BARI 2D Trial
Dr. C. Michael Gibson, Dr. Bernard Chaitman

Drs. Harrington and Gibson discuss the BARI 2D trial, factor 10a inhibitors, and the need for more sensitive bleeding me
Dr. Robert Harrington, MD, Dr. C. Michael Gibson, MD

Dr. Richard Karas and Dr. C. Michael Gibson discuss postmarket analysis of statins
Dr. C. Michael Gibson, Dr. Richard Karas

Dr. Michael Davidson and Dr. Duane Pinto discuss risk stratification and early treatment for diabetic patients
Dr. Duane Pinto, Dr. Michael Davidson

Dr. Victor Serebruany and Dr. C. Michael Gibson discuss the PLUTO-Diabetes trial
Dr. Victor Serebruany, Dr. C. Michael Gibson

Effect of Aspirin Dose on Platelet Reactivity in Diabetic Patients Paul A. Gurbel, MD
Dr. Paul Gurbel

Coronary Revascularization in Diabetic Patients - Optimizing Outcomes in 2007
Dr. David J. Cohen

STARR: The Study of Atherosclerosis with Ramipril and Rosiglitazone
Dr. Eva Lonn

Dr Gibson discusses Rosiglitazone and MI, decline in DES used after COURAGE
Dr. C. Michael Gibson

Dr Gibson discusses the Avandia controversy
Dr. C. Michael Gibson